Travel support request for US participants in BIOT-ESBES meeting (Istanbul, Turkey) from September 23-26, 2012

1246225/ kelly美国国家科学基金会生物技术、生化和生物质工程项目颁发的这一奖项将支持13位美国科学家和工程师参加将于2012年9月23日至26日在土耳其伊斯坦布尔举行的第九届欧洲生化工程研讨会（http://events.dechema.de/best2012）。生物工程和生物分子分离是此次BIOT、ESBES和ISPPP联合举办的活动的主要焦点。该研讨会将与第15届欧洲生物技术大会ECB15同时在同一地点举行，为参观所有这些大会的完整科学计划提供了独特的机会。本次峰会的目的是将这些领域的国际科学界聚集在一起，促进沟通、合作和跨学科的思想交流，以分析生命科学产业在解决人类面临的巨大挑战方面的影响。本次活动将为来自工业界和学术界的科学家提供一个独特的平台，以发现新的科学、技术、工艺和应用。会议由来自ESBES和William J. Kelly （Villanova University, PA/USA）的八名个人组成的协调小组组织，William J. Kelly作为ACS BIOT执行委员会的现任成员，代表ACS BIOT。成立了一个多样化的ACS BIOT小组委员会，目的是确定美国科学家和工程师，邀请他们在伊斯坦布尔举行的ECB15会议上担任技术演讲者和主题演讲者。这个会议是欧洲讨论这个多样化和迅速发展的领域的前沿研究的卓越场所。这次特别的会议为来自这四个不同但重叠的技术领域的美国科学家提供了一个独特的机会，让他们与欧洲同行进行互动。13位美国与会者将主要在以下领域主持或发表技术演讲：生物制药的前沿和创新、生物加工中的纳米技术、干细胞生物工程和细胞治疗、组织工程、系统生物技术和代谢工程。五名美国发言人受邀在启动会议上发表主题演讲，随后将在同一主题领域进行较短的技术演讲。更广泛的影响本次会议的重点将放在欧洲和美国生物技术领域的前沿研究上。会议组织者已经做出了巨大的努力，从科学和工程领域代表性不足的群体中邀请和招募美国演讲者和会议主席。来自明尼苏达大学的Claudia Schmidt-Dannert博士是做主题演讲的五位美国与会者之一。此外，13名美国参与者中有3名来自美国生物制药行业，其余7名是代表美国从西海岸到东海岸各大学的美国学者。由于BIOT和ESBES之间的首次合作，欧洲和美国在生物技术领域的旗舰科学组织的研究人员之间有机会增加交流。这是这两个重要研究团体之间加强互动的第一步。

1246225/ KellyThis award from the Biotechnology, Biochemical and Biomass Engineering Program of the National Science Foundation will support the participation of thirteen US scientists and engineers who are participating in the 9th European Symposium(http://events.dechema.de/best2012) on Biochemical Engineering to be held in Istanbul, Turkey from September 23-26, 2012. Bioengineering and the separation of biomolecules are the main focus of this jointly organized event of BIOT, ESBES and ISPPP. The symposium will take place at the same time and at the same place as ECB15, the 15th European Congress on Biotechnology, allowing for the unique opportunity to visit the complete scientific program of all these congresses. The idea of this summit is to bring together the international scientific communities in these fields, to foster communication, cooperation, and cross-disciplinary exchange of ideas in analyzing the impact of the life sciences industry in addressing humanity's great challenges. This event will provide a unique platform for scientists both from industry and academia to discover new science, technologies, processes and applications.The meeting is being organized by a coordination group consisting of eight individuals from ESBES and William J. Kelly (Villanova University, PA/USA) who, as a current member of the ACS BIOT executive board, is representing ACS BIOT. A diverse ACS BIOT subcommittee was created for the purposes of identifying US scientists and engineers to invite as technical presenters and keynote speakers at the ECB15 conference in Istanbul.Intellectual MeritThis conference is a pre-eminent venue in Europe for discussing research at the cutting edge of this diverse and rapidly expanding field. This particular meeting provides a unique opportunity for US scientists from not one but these four different but overlapping technical areas involved, to interact with their European counterparts. The thirteen US participants will be primarily chairing or giving technical presentations in the following areas: Frontiers and innovations in biopharmaceuticals, Nanotechnology in bioprocessing, Stem cell bioengineering and cell therapy and tissue engineering and Systems biotechnology and metabolic engineering. Five of the US speakers were invited to give keynote talks to launch sessions that would be followed by shorter technical talks in the same topical area.Broader ImpactsThe focus of this conference will be on research at the cutting-edge of the field of biotechnology in Europe and the US. The conference organizers have made a significant effort to invite and recruit US speakers and session chairs from groups underrepresented in science and engineering. Dr. Claudia Schmidt-Dannert from the University of Minnesota is one of the five US participants giving a keynote presentation. Furthermore, three of the thirteen US participants are from the US biopharmaceuticals industry and the remaining seven are US academics representing universities spanning the US from west to the east coasts. As a result of this first collaboration between BIOT and ESBES, there is the opportunity for increasing exchange between researchers in the flagship scientific organizations in Europe and the US in the areas of biotechnology. This is a first step in increased interaction between these two important research communities.